COL1A1 rs1799990: Understanding Bone Mineral Density Associations
The rs1799990 variant is a single-nucleotide polymorphism located within the COL1A1 gene, which provides instructions for making collagen. Research has investigated this variant for its potential associations with bone mineral density and the risk of bone fractures in various populations.
What each genotype means
Typical bone density profile
This genotype represents the common version of the COL1A1 Sp1 binding site polymorphism. Research suggests individuals with this profile do not carry the specific genetic association linked to increased fracture risk observed with the alternative allele. This is one of many factors influencing bone health, and overall bone density is determined by a complex interplay of genetics, lifestyle, and environment.
This is the most common genotype found in most global populations.
Increased fracture risk association
Studies have associated the 'T' allele (often referred to in older literature as the 's' allele) with lower bone mineral density and a higher risk of osteoporotic fractures. If you carry this genotype, you may have a statistically higher susceptibility to bone fragility compared to those without the variant. Please discuss your bone health and any concerns about fracture risk with your healthcare provider.
This heterozygous genotype is commonly observed across many populations, though exact frequencies vary by ancestry.
Elevated fracture risk association
Research indicates that individuals with this genotype (often referred to as the 'ss' genotype in historical studies) may experience a more pronounced reduction in bone mineral density and a higher incidence of vertebral fractures. This association is statistically significant but represents only one component of your total bone health profile. You should consult with a clinician to discuss appropriate bone density screening and lifestyle strategies.
This genotype is less common than the heterozygous form but is present in a significant portion of the population globally.
What is the rs1799990 Variant?
The rs1799990 variant is a specific change in the DNA sequence of the COL1A1 gene. In genetics, a single-nucleotide polymorphism (SNP) like rs1799990 represents a position where one of the four chemical bases—adenine, thymine, cytosine, or guanine—differs between individuals. This particular SNP is situated within the regulatory or coding regions of the COL1A1 gene, which is responsible for producing the alpha-1 chain of type I collagen. Collagen is a critical structural protein that acts as a building block for many tissues in the human body, including skin, tendons, and most importantly, bone. By studying these small variations, researchers aim to understand how subtle differences in our genetic code might influence the structural integrity of our skeletal system over a lifetime.
The Role of the COL1A1 Gene
The COL1A1 gene encodes the pro-alpha1 chain of type I collagen, the most abundant protein in the human body. Type I collagen is essential for providing tensile strength to connective tissues. In bone, this collagen forms a scaffold that is subsequently mineralized with calcium and phosphate to create hard, dense tissue. Mutations in the COL1A1 gene are well-documented as the primary cause of osteogenesis imperfecta, a condition characterized by extreme bone fragility. While rare, severe mutations can lead to significant skeletal deformities. In contrast, common variants like rs1799990 are studied for their more subtle effects on bone metabolism. These variants do not typically cause disease on their own but are investigated as potential contributors to the natural variation in bone mineral density observed across the general population.
Research and Evidence Strength
The association between COL1A1 variants and bone health has been a subject of extensive scientific inquiry. Genome-wide association studies (GWAS) have identified numerous SNPs linked to bone mineral density (BMD), a highly heritable trait. While some specific COL1A1 variants, such as rs1800012, have been frequently cited in literature regarding fracture risk and bone accrual, the evidence for rs1799990 is considered moderate. Scientific findings can vary based on the ancestry of the study participants, the age of the cohort, and environmental factors like nutrition and physical activity. It is important to note that bone density is a complex, polygenic trait, meaning it is influenced by the cumulative effect of many different genes and lifestyle factors. Consequently, a single SNP like rs1799990 provides only a small piece of the puzzle regarding an individual's overall skeletal health.
Population Frequency
The rs1799990 variant is considered a common polymorphism, meaning it is found at significant frequencies across diverse human populations. Genetic databases indicate that the alleles for this SNP are widely distributed, though the exact frequency can fluctuate between different ancestral groups. Because it is common, it is frequently included in large-scale genetic studies aimed at mapping the architecture of complex traits. These studies help researchers determine whether the variant's influence on bone density is consistent globally or if its effects are modified by other genetic or environmental factors unique to specific populations.
Interpreting Genetic Information
Understanding your genotype for a variant like rs1799990 is an exercise in exploring statistical associations rather than receiving a medical diagnosis. Because bone mineral density is influenced by a wide array of factors—including diet, exercise, hormonal status, and thousands of other genetic variants—this SNP cannot predict an individual's future bone health or fracture risk in isolation. Genetic information should never be used to make independent medical decisions or to alter treatment plans. If you have concerns about your bone health, such as questions about osteoporosis or fracture risk, it is essential to consult with a healthcare professional. A doctor can evaluate your clinical history, perform appropriate screenings like a DXA scan, and provide personalized guidance based on your overall health profile.
How common is this variant?
The rs1799990 variant is a common SNP found across diverse global populations, with its specific genotype frequencies varying by ancestry.
Frequently asked questions
Can this SNP predict if I will get osteoporosis?
No, this SNP cannot predict if you will develop osteoporosis. Bone mineral density is a complex trait influenced by many genes, lifestyle choices, and environmental factors, and this variant only has a minor statistical association.
Should I change my diet based on my COL1A1 genotype?
You should not change your diet based on this genotype. Always consult with a registered dietitian or your primary care physician before making significant changes to your nutrition or supplement regimen.
Is rs1799990 the same as the COL1A1 Sp1 polymorphism?
No, rs1799990 is a distinct variant. The Sp1 polymorphism often discussed in bone health research is typically identified as rs1800012.
Where can I find more information about my bone health?
For reliable information regarding your bone health, you should speak with your healthcare provider. They can discuss appropriate screening tests, such as bone density scans, based on your age, sex, and medical history.
Sources & further reading
Educational information only, last refreshed 10/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1799990?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in COL1A1
This SNP is linked to an age-protective methylation marker in collagen genes, influencing perceived facial aging.
The Sp1 binding site polymorphism in COL1A1 has been extensively studied for associations with bone mineral density (BMD) and fracture risk, though results remain inconsistent across different populations.
An intronic Sp1 transcription factor binding-site variant (often termed the +1245 G/T or Sp1 polymorphism) that influences type I collagen alpha-1 chain synthesis, impacting tendon elasticity, cruciate ligament tear risk, and bone mineral density under mechanical loading.
Regulates Sp1 binding affinity within the COL1A1 regulatory promoter, modulating baseline bone mineral density and connective tissue flexibility traits.
A promoter polymorphism (-1997G/T) in type I collagen alpha 1 that regulates transcriptional activity and alters susceptibility to anterior cruciate ligament ruptures and tendon pathology.
Intronic collagen type I alpha 1 variant associated with cruciate ligament rupture risk and tendon tensile stiffness in sports performance.